These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization. Komala Sari T, Gianopulos KA, Nicola AV. J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995 [Abstract] [Full Text] [Related]
7. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. Nemerow GR, Jensen FC, Cooper NR. J Clin Invest; 1982 Nov 14; 70(5):1081-91. PubMed ID: 6290536 [Abstract] [Full Text] [Related]
13. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. J Virol; 2008 Jul 14; 82(14):6935-41. PubMed ID: 18480440 [Abstract] [Full Text] [Related]
14. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH. Virology; 2002 Mar 15; 294(2):324-32. PubMed ID: 12009874 [Abstract] [Full Text] [Related]
17. Replication-Competent Controlled Herpes Simplex Virus. Bloom DC, Feller J, McAnany P, Vilaboa N, Voellmy R. J Virol; 2015 Oct 15; 89(20):10668-79. PubMed ID: 26269179 [Abstract] [Full Text] [Related]
18. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM. J Immunol; 1986 Sep 01; 137(5):1636-41. PubMed ID: 3018078 [Abstract] [Full Text] [Related]